Showing 6871-6880 of 9883 results for "".
- Revision Skincare Announces Partnership with World Champion Gymnast Aly Raismanhttps://practicaldermatology.com/news/revision-skincare-announces-partnership-with-world-champion-gymnast-aly-raisman/2458824/World Champion gymnast and three-time Olympic gold medalist Aly Raisman is now an ambassador for the Revision Skincare brand. “My partnership with Revision Skincare is very important to me because I used to struggle with skin problems before using their products,” Ms. Raisman
- Research Shows Skin Can Reflect Eating Habitshttps://practicaldermatology.com/news/research-shows-skin-can-reflect-eating-habits/2458822/Dermatologists at Baylor College of Medicine say there is evidence that links certain foods to flares in acne. “While there are definitely a number of triggers for acne, the connection between diet and acne is very interesting,” said Dr. Rajani Katta, professor of dermatology
- Provectus Biopharmaceuticals: Immune Mechanism of Action Data for PV-10 Presented at Society for Immunotherapy of Cancer Annual Meetinghttps://practicaldermatology.com/news/provectus-biopharmaceuticals-immune-mechanism-of-action-data-for-pv-10-presented-at-society-for-immunotherapy-of-cancer-annual-meeting/2458823/Researchers from Moffitt Cancer Center in Tampa, FL, presented a poster titled, “Intralesional Rose Bengal in Melanoma Elicits Tumor Immunity via High Mobility Group Box 1,” at the Society for Immunotherapy of Cancer (SITC) 30th Anniversary Annual Meeting in National Harbor, MD, accor
- Dr. Mandy Honored with ASDS Stegman Awardhttps://practicaldermatology.com/news/dr-mandy-honored-with-asds-stegman-award/2458828/Stephen H. Mandy, M.D., of Miami Beach, FL, was presented recently with the Samuel J. Stegman, MD, Award for Distinguished Service, the highest honor bestowed by the American Society for Dermatologic Surgery (ASDS). The Stegman Award – given to Dr. Mandy during the 2015 ASDS Annual
- Revance Reports Positive 6-Month Duration for RT002 in BELMONT Studyhttps://practicaldermatology.com/news/revance-reports-positive-6-month-duration-for-rt002-in-belmont-study/2458831/Revance Therapeutics, Inc., shared positive 24-week results from its multi-center BELMONT Phase 2 active comparator study of injectable RT002. The ongoing study for the treatment of glabellar lines in 268 subjects compared the safety, efficacy, and duration of effect of three doses of RT002
- SecurityMetrics: HIPAA Report Reveals Healthcare's Shortcomingshttps://practicaldermatology.com/news/hipaa-report-reveals-healthcares-shortcomings/2458840/A significant security disparity exists among healthcare c-suite and IT departments, outlined by the SecurityMetrics HIPAA Security Rule Report. In a survey of c-level, risk officers, and IT managers, a 10-20% gap was revealed between what executives believe is happening in regards to patient dat
- One Quarter of Americans Misled by Online Info: Surveyhttps://practicaldermatology.com/news/one-quarter-of-americans-misled-by-online-info-survey/2458841/One in four Americans (24 percent) say they have been misled by information about an illness or medical symptom from an unverified online source, according to a new survey from Merck Manuals. That figure increases to 30 percent among parents with children under 18 and jumps to 43 percent among mi
- OHSU Releases Mole Mapper App to Track Potential Skin Cancershttps://practicaldermatology.com/news/ohsu-releases-mole-mapper-app-to-track-potential-skin-cancers/2458843/Oregon Health & Science University released an iPhone app it says is designed to advance melanoma research by giving users the ability to accurately measure and monitor moles, and contribute photos of how their potential trouble spots evolve over time. Called Mole Mapper, the app is free to d
- Study Demonstrates Duac Significantly Reduces Inflammatory Acne Lesionshttps://practicaldermatology.com/news/study-demonstrates-duac-significantly-reduces-inflammatory-acne-lesions/2458846/Stiefel shared the findings of a head-to-head German study demonstrating that, in patients with mild-to-moderate acne vulgaris, treatment with Duac™ 3% (benzoyl peroxide 3% + clindamycin 1%) led to numerically fewer inflammatory and non-inflammatory lesions from baseline compared to treatme
- A Novel Dual-Wavelength, Nd:YAG, Picosecond-domain Laser Safely and Effectively Removes Multicolor Tattooshttps://practicaldermatology.com/news/a-novel-dual-wavelength-ndyag-picosecond-domain-laser-safely-and-effectively-removes-multicolor-tattoos/2458848/Research conducted by Eric F. Bernstein MD, MSc; Kevin T. Schomacker PhD; Lisa D. Basilavecchio RN; Jessica M. Plugis; and Jayant D. Bhawalkar PhD, published in the September 2015 issue of Lasers in Surgery and Medicine (LSM), evaluated 21 tattooed subjects between the ages of 19-55 who